Laminar Pharmaceuticals
Manufacturing · Spain · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Ctra Valldemossa Mód c-8 Km. 7,4 Parcbit...Phone Number
(978) 631-0600Website
www.laminarpharma.comRevenue
<$5 MillionIndustry
About Laminar Pharmaceuticals
Laminar Pharma is a pioneering biopharmaceutical company dedicated to the discovery, design, and initial clinical development of next-generation medicines. The company specializes in a novel therapeutic approach known as melitherapy, focusing on first-in-class molecules that target membrane lipids. Laminar Pharma aims to provide reference treatments for diseases with unmet medical needs, including cancer and Alzheimer's disease. Their innovative pipeline includes products like LAM561, LAM226, and LAM204, which are currently undergoing clinical trials.Explore more
Laminar Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Laminar Pharmaceuticals
Compare insights from companies similar to Laminar Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Laminar Pharmaceuticals Tech Stack
A closer look at the technologies used by Laminar Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Laminar Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Laminar Pharma is a pioneering biopharmaceutical company dedicated to the discovery, design, and initial clinical development of next-generation medicines. The company specializes in a novel therapeutic approach known as melitherapy, focusing on first-in-class molecules that target membrane lipids. Laminar Pharma aims to provide reference treatment... Read More
